Rheumacare capsules, 30 count bottle
Recalled by HANDELNINE GLOBAL LLC
Drug recall
HANDELNINE GLOBAL LLC
Class I — most serious
There is a reasonable chance that using this product could cause serious health problems or death.
HANDELNINE GLOBAL LLC has recalled Rheumacare capsules, 30 count bottle, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on February 11, 2026 and was initiated on December 22, 2025. It is classified as a Class I recall, which means there is a reasonable chance that using this product could cause serious health problems or death.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Rheumacare capsules, 30 count bottle, with approximately 4 bottles /30 capsules each affected. The company behind the recall is HANDELNINE GLOBAL LLC, based in South Plainfield, NJ. The FDA describes the product as: “Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313”
Why was Rheumacare capsules, 30 count bottle recalled?
According to the FDA, the stated reason for the recall is: “CGMP Deviations: product found to contain lead.” In plain terms, this recall relates to elevated levels of a heavy metal.
Some recalls are issued when testing finds elevated levels of a heavy metal such as lead. Long-term exposure to certain heavy metals is a recognized health concern, particularly for young children. Regulators set limits and recall products that exceed them.
What should you do?
If you think you may have bought Rheumacare capsules, 30 count bottle, compare it against the product description and identifying codes (Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact HANDELNINE GLOBAL LLC or your local health authority.
About this recall
This recall was distributed in NJ. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- February 11, 2026
- Recall started
- December 22, 2025
- Distributed in
- NJ
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Rheumacare capsules, 30 count bottle recalled?+
According to the FDA: CGMP Deviations: product found to contain lead.
How serious is this recall?+
Class I — most serious. There is a reasonable chance that using this product could cause serious health problems or death.
What should I do if I have Rheumacare capsules, 30 count bottle?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0332-2026. Information last synced from the FDA on July 6, 2026.